FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387617961> ?p ?o ?g. }

• W4387617961 abstract "In recent years, several novel agents have become available to treat individuals with type 2 diabetes (T2D), such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i), tirzepatide, which is a dual glucose-dependent insulinotropic polypeptide receptor agonist (GIP RA)/glucagon-like peptide-1 receptor agonist (GLP-1 RA), and finerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA) that confers significant renal and cardiovascular benefits in individuals with (CKD). New medications have the potential to improve the lives of individuals with diabetes. However, clinicians are challenged to understand the benefits and potential risks associated with these new and emerging treatment options. In this article, we discuss how use of network meta-analyses (NMA) can fill this need." @default.
• W4387617961 created "2023-10-14" @default.
• W4387617961 creator A5000893155 @default.
• W4387617961 creator A5003676386 @default.
• W4387617961 creator A5011161870 @default.
• W4387617961 creator A5013109449 @default.
• W4387617961 creator A5017952355 @default.
• W4387617961 creator A5019976194 @default.
• W4387617961 creator A5020174004 @default.
• W4387617961 creator A5031812511 @default.
• W4387617961 creator A5031856386 @default.
• W4387617961 creator A5036886342 @default.
• W4387617961 creator A5036949656 @default.
• W4387617961 creator A5049778994 @default.
• W4387617961 creator A5052533254 @default.
• W4387617961 creator A5070855397 @default.
• W4387617961 creator A5071193014 @default.
• W4387617961 creator A5082101100 @default.
• W4387617961 creator A5082499548 @default.
• W4387617961 creator A5086369928 @default.
• W4387617961 creator A5090174827 @default.
• W4387617961 date "2023-10-13" @default.
• W4387617961 modified "2023-10-15" @default.
• W4387617961 title "Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop" @default.
• W4387617961 cites W1247968195 @default.
• W4387617961 cites W2067661817 @default.
• W4387617961 cites W2093770528 @default.
• W4387617961 cites W2096074908 @default.
• W4387617961 cites W2472937910 @default.
• W4387617961 cites W2558697804 @default.
• W4387617961 cites W2784276839 @default.
• W4387617961 cites W3006906125 @default.
• W4387617961 cites W3007693026 @default.
• W4387617961 cites W3099906708 @default.
• W4387617961 cites W3164321167 @default.
• W4387617961 cites W3177122952 @default.
• W4387617961 cites W4200557705 @default.
• W4387617961 cites W4206077470 @default.
• W4387617961 cites W4210940103 @default.
• W4387617961 cites W4211156932 @default.
• W4387617961 cites W4281725730 @default.
• W4387617961 cites W4281934192 @default.
• W4387617961 cites W4283256982 @default.
• W4387617961 cites W4283834854 @default.
• W4387617961 cites W4327585971 @default.
• W4387617961 cites W4362693001 @default.
• W4387617961 doi "https://doi.org/10.1186/s12933-023-01993-3" @default.
• W4387617961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37833776" @default.
• W4387617961 hasPublicationYear "2023" @default.
• W4387617961 type Work @default.
• W4387617961 citedByCount "0" @default.
• W4387617961 crossrefType "journal-article" @default.
• W4387617961 hasAuthorship W4387617961A5000893155 @default.
• W4387617961 hasAuthorship W4387617961A5003676386 @default.
• W4387617961 hasAuthorship W4387617961A5011161870 @default.
• W4387617961 hasAuthorship W4387617961A5013109449 @default.
• W4387617961 hasAuthorship W4387617961A5017952355 @default.
• W4387617961 hasAuthorship W4387617961A5019976194 @default.
• W4387617961 hasAuthorship W4387617961A5020174004 @default.
• W4387617961 hasAuthorship W4387617961A5031812511 @default.
• W4387617961 hasAuthorship W4387617961A5031856386 @default.
• W4387617961 hasAuthorship W4387617961A5036886342 @default.
• W4387617961 hasAuthorship W4387617961A5036949656 @default.
• W4387617961 hasAuthorship W4387617961A5049778994 @default.
• W4387617961 hasAuthorship W4387617961A5052533254 @default.
• W4387617961 hasAuthorship W4387617961A5070855397 @default.
• W4387617961 hasAuthorship W4387617961A5071193014 @default.
• W4387617961 hasAuthorship W4387617961A5082101100 @default.
• W4387617961 hasAuthorship W4387617961A5082499548 @default.
• W4387617961 hasAuthorship W4387617961A5086369928 @default.
• W4387617961 hasAuthorship W4387617961A5090174827 @default.
• W4387617961 hasBestOaLocation W43876179611 @default.
• W4387617961 hasConcept C126322002 @default.
• W4387617961 hasConcept C134018914 @default.
• W4387617961 hasConcept C142724271 @default.
• W4387617961 hasConcept C170493617 @default.
• W4387617961 hasConcept C177713679 @default.
• W4387617961 hasConcept C185280430 @default.
• W4387617961 hasConcept C189135053 @default.
• W4387617961 hasConcept C2777180221 @default.
• W4387617961 hasConcept C2778938600 @default.
• W4387617961 hasConcept C2780182762 @default.
• W4387617961 hasConcept C555293320 @default.
• W4387617961 hasConcept C60644358 @default.
• W4387617961 hasConcept C71924100 @default.
• W4387617961 hasConcept C86803240 @default.
• W4387617961 hasConceptScore W4387617961C126322002 @default.
• W4387617961 hasConceptScore W4387617961C134018914 @default.
• W4387617961 hasConceptScore W4387617961C142724271 @default.
• W4387617961 hasConceptScore W4387617961C170493617 @default.
• W4387617961 hasConceptScore W4387617961C177713679 @default.
• W4387617961 hasConceptScore W4387617961C185280430 @default.
• W4387617961 hasConceptScore W4387617961C189135053 @default.
• W4387617961 hasConceptScore W4387617961C2777180221 @default.
• W4387617961 hasConceptScore W4387617961C2778938600 @default.
• W4387617961 hasConceptScore W4387617961C2780182762 @default.
• W4387617961 hasConceptScore W4387617961C555293320 @default.
• W4387617961 hasConceptScore W4387617961C60644358 @default.
• W4387617961 hasConceptScore W4387617961C71924100 @default.
• W4387617961 hasConceptScore W4387617961C86803240 @default.

• next